Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mechanisms Involved in Altered Bone Metabolism in Diabetes: A Narrative Review Publisher



Ghodsi M1 ; Larijani B2 ; Keshtkar AA3 ; Nasliesfahani E1 ; Alatab S4 ; Mohajeritehrani MR2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences (TUMS), Diabetes Research Center (DRC), Endocrinology and Metabolism Research Institute (EMRI), Tehran, Iran
  2. 2. Tehran University of Medical Sciences (TUMS), Endocrinology and Metabolism Research Center (EMRC), Endocrinology and Metabolism Resarch Institute (EMRI), Tehran, Iran
  3. 3. Tehran University of Medical Sciences (TUMS), Department of Health Sciences Education Development, School of Public Health (SPH), Tehran, Iran
  4. 4. Urology Research Center (URC), Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2016


Abstract

Many studies have shown that change in metabolism caused by diabetes can influence the bone metabolism in a way that quality and strength of bone is decreased. A 6 times and 2 times increased risk of fracture is reported in patients with type 1 and type 2 diabetes, respectively. There are several mechanisms by which diabetes can affect the bone. The fact that some of these mechanisms are acting in opposite ways opens the door for debate on pathways by which diabetes affects the bones. On the other hand, bone is not a simple organ that only get influence from other organs, but it is an endocrine organ that by secreting the agents such as osteocalcin, adiponectin and visfatin which can affect the insulin sensitivity and metabolism. In this paper we tried to briefly assess the latest finding in this matter. © 2016 The Author(s).
Other Related Docs
27. Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (Mets): A Meta-Analysis, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
28. Visfatin in Obese Children and Adolescents and Its Association With Insulin Resistance and Metabolic Syndrome, Scandinavian Journal of Clinical and Laboratory Investigation (2015)